Abstract:Amyloid- β peptides (Aβ) participate in the development of Alzheimer's disease (AD). AD brains accumulate multiple forms of Aβ peptides, composed of Aβ(1–40/42) with pyroglutamate-Aβ(3–40/42) (pGlu-A β) present as a major portion of Aβ. Several studies estimate that pGlu-A β comprises approximately 50% or more of total A β (Saido et al., 1995; Kuo et al., 1997). The pGlu-Aβ(3–40/42) is hypothesized to facilitate the oligomerization of Aβ(1–40/42) (Schilling et al., 2006) to result in neurotoxicity. The formation of pGlu-Aβ(3–40/42) is produced from the substrate Aβ(3–40/42), which may be generated by a beta-secretase-dependent or -independent mechanism. Cathepsin B has been shown to generate A β(1–40/42) from AD mice expressing APP with the wild-type beta-secretase site (Kindy et al., 2012) expressed in the majority of AD patients. This study, therefore, addresses the role of cathepsin B, possessing wild-type beta-secretase function, in producing pGlu-Aβ(3–40/42). Knockout of the cathepsin B gene was conducted in the APP/Lon mouse model of AD. The APP/Lon mice were also treated with E64d, inhibitor of cathepsin B, by oral administration. Brains were then assessed for levels of pGlu-Aβ(3–40/42) and Aβ(1–40/42), amyloid plaque; animals were evaluated for memory function by the Morris water maze test. Knockout of the cathepsin B gene in the APP/Lon AD mouse model, expressing APP with the wild-type beta-secretase site, was assessed. Knockout of the cathepsin gene resulted in a significant reduction in brain pGlu-Aβ(3–40/42) as well as Aβ(1–40/42). Chemical inhibition of cathepsin B, conducted by oral administration of the E64d inhibitor, in the APP/Lon mice reduced brain pGlu-Aβ(3–40/42) and Aβ(1–40/42). Also, cathepsin B inhibition and gene knockout reduced brain amyloid plaque accumulation and improved memory function in the APP/Lon mice. Cellular studies show that pGlu-Aβ(3–40) is secreted from the regulated secretory pathway of neuronal-like chromaffin cells, and inhibition of cathepsin B (with CA074Me) reduces pGlu-A β(3–40). Results from knockout of the cathepsin B gene in the APP/Lon AD mouse model show that cathepsin B participates in the production of pGlu-Aβ(3–40/42), as well as A β(1–40/42). Cathepsin B inhibitors will likely be effective at reducing neurotoxic pGlu-Aβ(3–40/42), as well as Aβ(1–40/42), for improvement of memory function in AD.

Inhibition of Tissue Transglutaminase Promotes Aβ-induced Apoptosis in SH-SY5Y Cells

Inhibition of Tissue Transglutaminase Attenuates Lipopolysaccharide-Induced Inflammation in Glial Cells Through Akt/Mtor Signal Pathway

P3‐309: Overexpression of Hyperphosphorylated Tau Antagonizes Aβ‐potentiated Apoptosis with Preservation of Mitochondrial Elements

Tissue Transglutaminase and Its Product Isopeptide Are Increased in Alzheimer'S Disease and Appswe/Ps1de9 Double Transgenic Mice Brains

Protective effect of EGb761 against Aβ1-42 -induced SHSY5Y cells injury and blood-brain barrier disruption via regulating Akt/Nrf2 signaling pathway

Caspase-8 Mediates Amyloid-β-induced Apoptosis in Differentiated PC12 Cells

Tau Protein Antagonizes Cell Apoptosis Through Akt Pathway

Tenuigenin Treatment Decreases Secretion of the Alzheimer’s Disease Amyloid Β-Protein in Cultured Cells

The role and mechanism of TanshinoneⅡA on β-amyloid_(25-35)

Cryptotanshinone Attenuates Amyloid-β42-induced Tau Phosphorylation by Regulating PI3K/Akt/GSK3β Pathway in HT22 Cells

Inhibition of Γ-Secretase Activity Reduces Aβ Production, Reduces Oxidative Stress, Increases Mitochondrial Activity and Leads to Reduced Vulnerability to Apoptosis: Implications for the Treatment of Alzheimer's Disease

TGF-β Induces TIAF1 Self-Aggregation Via Type II Receptor-Independent Signaling That Leads to Generation of Amyloid Β Plaques in Alzheimer's Disease.

Tβ4 Ameliorates Oxidative Damage and Apoptosis Through ERK/MAPK and 5-HT1A Signaling Pathway in Aβ Insulted SH-SY5Y Cells.

Therapeutic Effect of Transmembrane TAT-tCNTF Via Erk and Akt Activation Using in Vitro and in Vivo Models of Alzheimer's Disease.

Trilobatin Protects Against Aβ25–35-Induced Hippocampal HT22 Cells Apoptosis Through Mediating ROS/p38/Caspase 3-Dependent Pathway

Mutated recombinant human glucagon-like peptide-1 protects SH-SY5Y cells from apoptosis induced by amyloid-β peptide (1–42)

Apoptosis of endoplasmic reticulum stress-specific induced endoplasmic by Aβ and effect of tetrahydroxy stilbene glucoside on it

Effect of Overexpressed Transmembrane Protein 21 on Activity of Β-Secretase Involved in Alzheimer's

TGF-β1 protection against Aβ1-42-induced neuroinflammation and neurodegeneration in rats

MLK3‐MKK3/6‐P38MAPK Cascades Following N‐methyl‐D‐aspartate Receptor Activation Contributes to Amyloid‐β Peptide‐induced Apoptosis in SH‐SY5Y Cells

O1–08–02: Cathepsin B Produces Brain Pyro‐glu‐beta‐amyloid in a Transgenic Alzheimer's Disease Mouse Model